DRAGARWQ
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
- 
                
Share Price
 - 
                
Financials
 - 
                
Revenue mix
 - 
                
Shareholdings
 - 
                
Peers
 - 
                
Forensics
 
- 5D
 - 1M
 - 6M
 - YTD
 - 1Y
 - 5Y
 - MAX
 
This data is currently unavailable for this company.
- 
            
Summary
 - 
            
Profit & Loss
 - 
            
Balance sheet
 - 
            
Cashflow
 
This data is currently unavailable for this company.
| (In Cr.) | 
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
| 
                        
                         This data is currently unavailable for this company.  | 
                    
| (In %) | 
|---|
| (In Cr.) | 
|---|
| Financial Year (In Cr.) | 
|---|
- 
        
Product wise
 - 
        
Location wise
 
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
- 
                
News
 - 
                
Corporate Actions
 
Dr Agarwal's Eye Hospital Says Dividend Of 2.50 Rupees Per Share
Oct 29 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
DR AGARWAL'S EYE HOSPITAL LTD - DIVIDEND OF 2.50 RUPEES PER SHARE
Source text: ID:nBSE42jyZh
Further company coverage: DRAG.BO
(([email protected];;))
Oct 29 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
DR AGARWAL'S EYE HOSPITAL LTD - DIVIDEND OF 2.50 RUPEES PER SHARE
Source text: ID:nBSE42jyZh
Further company coverage: DRAG.BO
(([email protected];;))
Dr Agarwal's Eye Hospital Dividend 2.5 Rupees Per Share
April 25 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
DIVIDEND 2.5 RUPEES PER SHARE
Source text for Eikon: ID:nBSE70tcdG
Further company coverage: DRAG.BO
(([email protected];))
April 25 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
DIVIDEND 2.5 RUPEES PER SHARE
Source text for Eikon: ID:nBSE70tcdG
Further company coverage: DRAG.BO
(([email protected];))
Dr Agarwal's Eye Hospital Sept-Quarter Net PAT Rises
Oct 20 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
DR AGARWAL'S EYE HOSPITAL LTD - DIVIDEND OF 2.5 RUPEES PER SHARE
INDIA'S DR AGARWAL'S EYE HOSPITAL SEPT-QUARTER NET PAT 125.9 MILLION RUPEES VERSUS 90.7 MILLION RUPEES
DR AGARWAL'S EYE HOSPITAL SEPT-QUARTER REVENUE FROM OPERATIONS 832.7 MILLION RUPEES VERSUS 687.5 MILLION RUPEES
Source text for Eikon: ID:nBSE8hH8Vh
Further company coverage: DRAG.BO
(([email protected];))
Oct 20 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
DR AGARWAL'S EYE HOSPITAL LTD - DIVIDEND OF 2.5 RUPEES PER SHARE
INDIA'S DR AGARWAL'S EYE HOSPITAL SEPT-QUARTER NET PAT 125.9 MILLION RUPEES VERSUS 90.7 MILLION RUPEES
DR AGARWAL'S EYE HOSPITAL SEPT-QUARTER REVENUE FROM OPERATIONS 832.7 MILLION RUPEES VERSUS 687.5 MILLION RUPEES
Source text for Eikon: ID:nBSE8hH8Vh
Further company coverage: DRAG.BO
(([email protected];))
Indian eye hospital chain Dr. Agarwal's raises $80 mln from TPG, Temasek
Adds revenue forecast in paragraph 3
CHENNAI, Aug 17 (Reuters) - Dr. Agarwal's Health Care said on Thursday it raised $80 million from existing investors Singapore's Temasek and U.S.-based TPG as the Indian eye hospital operator plans to double its hospital count.
The top shareholder of publicly listed Dr. Agarwal's Eye Hospitals DRAG.BO plans to operate 300 hospitals by the end of 2025. It currently has over 150 hospitals, including in African countries like Nigeria and Kenya.
Shares of the company rose as much as 10.3%, before paring some gains to last trade up 5.1%.
The firm is aiming revenue of about 15 billion rupees for the current financial year and up to 25 billion rupees within the next three, CEO Adil Agarwal said.
Dr. Agarwal's will invest over 12 billion rupees ($144.45 million) to set up new hospitals in India and 10 centres in the African countries of Kenya, Zambia, and Tanzania, it said in a press release.
The fundraise also comes over a year after Dr. Agarwal's – founded in 1957 in the southern Indian city of Chennai – closed a funding round of 10.50 billion rupees from Temasek and TPG Growth, the middle market-focused arm of TPG TPG.O.
Private care is becoming more and more popular in India due to a growing and ageing population, as well as rise in income levels. The pandemic has sharpened people's focus on health and wellness.
Spotting the trend, global investors are scouting the around $48 billion Indian private healthcare market, with Temasek itself spending $2 billion in April to lift its stake in multi-specialty chain Manipal Hospitals by 41% to 59%.
($1 = 83.0760 Indian rupees)
(Reporting by Praveen Paramasivam in Chennai; Editing by Nivedita Bhattacharjee)
(([email protected]; +91 867-525-3569;))
Adds revenue forecast in paragraph 3
CHENNAI, Aug 17 (Reuters) - Dr. Agarwal's Health Care said on Thursday it raised $80 million from existing investors Singapore's Temasek and U.S.-based TPG as the Indian eye hospital operator plans to double its hospital count.
The top shareholder of publicly listed Dr. Agarwal's Eye Hospitals DRAG.BO plans to operate 300 hospitals by the end of 2025. It currently has over 150 hospitals, including in African countries like Nigeria and Kenya.
Shares of the company rose as much as 10.3%, before paring some gains to last trade up 5.1%.
The firm is aiming revenue of about 15 billion rupees for the current financial year and up to 25 billion rupees within the next three, CEO Adil Agarwal said.
Dr. Agarwal's will invest over 12 billion rupees ($144.45 million) to set up new hospitals in India and 10 centres in the African countries of Kenya, Zambia, and Tanzania, it said in a press release.
The fundraise also comes over a year after Dr. Agarwal's – founded in 1957 in the southern Indian city of Chennai – closed a funding round of 10.50 billion rupees from Temasek and TPG Growth, the middle market-focused arm of TPG TPG.O.
Private care is becoming more and more popular in India due to a growing and ageing population, as well as rise in income levels. The pandemic has sharpened people's focus on health and wellness.
Spotting the trend, global investors are scouting the around $48 billion Indian private healthcare market, with Temasek itself spending $2 billion in April to lift its stake in multi-specialty chain Manipal Hospitals by 41% to 59%.
($1 = 83.0760 Indian rupees)
(Reporting by Praveen Paramasivam in Chennai; Editing by Nivedita Bhattacharjee)
(([email protected]; +91 867-525-3569;))
India's Dr Agarwal's Eye Hospital June-Quarter Net PAT Rises
Aug 4 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
JUNE-QUARTER NET PAT 115.4 MILLION RUPEES VERSUS 91.1 MILLION RUPEES YEAR AGO
JUNE-QUARTER REVENUE FROM OPERATIONS 778 MILLION RUPEES VERSUS 663.9 MILLION RUPEES YEAR AGO
Further company coverage: DRAG.BO
(([email protected];))
Aug 4 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
JUNE-QUARTER NET PAT 115.4 MILLION RUPEES VERSUS 91.1 MILLION RUPEES YEAR AGO
JUNE-QUARTER REVENUE FROM OPERATIONS 778 MILLION RUPEES VERSUS 663.9 MILLION RUPEES YEAR AGO
Further company coverage: DRAG.BO
(([email protected];))
India's Dr Agarwal's Eye Hospital Ltd March-Quarter Net PAT Rises
May 10 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
FINAL DIVIDEND OF 3 RUPEES PER SHARE
MARCH-QUARTER NET PAT 136.8 MILLION RUPEES VERSUS 68.7 MILLION RUPEES
MARCH-QUARTER REVENUE FROM OPERATIONS 692.1 MILLION RUPEES VERSUS 556.6 MILLION RUPEES
Source text for Eikon: ID:nBSE6hVQdy
Further company coverage: DRAG.BO
(([email protected];))
May 10 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
FINAL DIVIDEND OF 3 RUPEES PER SHARE
MARCH-QUARTER NET PAT 136.8 MILLION RUPEES VERSUS 68.7 MILLION RUPEES
MARCH-QUARTER REVENUE FROM OPERATIONS 692.1 MILLION RUPEES VERSUS 556.6 MILLION RUPEES
Source text for Eikon: ID:nBSE6hVQdy
Further company coverage: DRAG.BO
(([email protected];))
Upcoming Events:
Dividend
Events:
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- 
                
Business
 - 
                
Financials
 - 
                
Share Price
 - 
                
Shareholdings
 
What does Dr Agarwals Eye Hsp do?
Dr Agarwals Eye Hospital Ltd is a leading medical facility in the field of Ophthalmic care, known for its pioneering medical advancements, highly skilled specialists, and a wide range of services including surgeries and customized eye treatments.
Who are the competitors of Dr Agarwals Eye Hsp?
Dr Agarwals Eye Hsp major competitors are Apollo Hospital Ent., Max Healthcare Inst, Fortis Healthcare, Global Health, Narayana Hrudayalay, Krishna Inst.Medi, Aster DM Healthcare. Market Cap of Dr Agarwals Eye Hsp is ₹2,530 Crs. While the median market cap of its peers are ₹35,865 Crs.
Is Dr Agarwals Eye Hsp financially stable compared to its competitors?
Dr Agarwals Eye Hsp seems to be less financially stable compared to its competitors. Altman Z score of Dr Agarwals Eye Hsp is 4.57 and is ranked 8 out of its 8 competitors.
Does Dr Agarwals Eye Hsp pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Dr Agarwals Eye Hsp latest dividend payout ratio is 5.16% and 3yr average dividend payout ratio is 4.68%
How has Dr Agarwals Eye Hsp allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Dr Agarwals Eye Hsp balance sheet?
Balance sheet of Dr Agarwals Eye Hsp is strong. But short term working capital might become an issue for this company.
Is the profitablity of Dr Agarwals Eye Hsp improving?
Yes, profit is increasing. The profit of Dr Agarwals Eye Hsp is ₹62.97 Crs for TTM, ₹54.65 Crs for Mar 2025 and ₹46.36 Crs for Mar 2024.
Is the debt of Dr Agarwals Eye Hsp increasing or decreasing?
Yes, The net debt of Dr Agarwals Eye Hsp is increasing. Latest net debt of Dr Agarwals Eye Hsp is ₹81.28 Crs as of Sep-25. This is greater than Mar-25 when it was ₹73.22 Crs.
Is Dr Agarwals Eye Hsp stock expensive?
Yes, Dr Agarwals Eye Hsp is expensive. Latest PE of Dr Agarwals Eye Hsp is 40.18, while 3 year average PE is 27.41. Also latest EV/EBITDA of Dr Agarwals Eye Hsp is 19.43 while 3yr average is 12.62.
Has the share price of Dr Agarwals Eye Hsp grown faster than its competition?
Dr Agarwals Eye Hsp has given lower returns compared to its competitors. Dr Agarwals Eye Hsp has grown at ~37.84% over the last 2yrs while peers have grown at a median rate of 38.64%
Is the promoter bullish about Dr Agarwals Eye Hsp?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 72.67% and last quarter promoter holding is 71.9%.
Are mutual funds buying/selling Dr Agarwals Eye Hsp?
The mutual fund holding of Dr Agarwals Eye Hsp is increasing. The current mutual fund holding in Dr Agarwals Eye Hsp is 0.18% while previous quarter holding is 0.12%.
